Lamotrigine Pregnancy Registry (LAM05)

Trial Profile

Lamotrigine Pregnancy Registry (LAM05)

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Lamotrigine (Primary) ; Antiepileptic drugs; Valproic acid
  • Indications Bipolar disorders; Epilepsy
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 25 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Nov 2010 Planned end date changed from 1 Jul 2015 to 1 Jul 2010 as reported by ClinicalTrials.gov.
    • 22 Nov 2010 Planned End Date changed from 1 Jan 2015 to 1 Jul 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top